Literature DB >> 20934424

Suppressor of cytokine signalling (SOCS) 1 and 3 enhance cell adhesion and inhibit migration towards the chemokine eotaxin/CCL11.

Nigel J Stevenson1, Cheryl McFarlane, Seow Theng Ong, Krystyna Nahlik, Alyson Kelvin, Mark R Addley, Aideen Long, David R Greaves, Cliona O'Farrelly, James A Johnston.   

Abstract

Suppressors of cytokine signalling (SOCS) proteins regulate signal transduction, but their role in responses to chemokines remains poorly understood. We report that cells expressing SOCS1 and 3 exhibit enhanced adhesion and reduced migration towards the chemokine CCL11. Focal adhesion kinase (FAK) and the GTPase RhoA, control cell adhesion and migration and we show the presence of SOCS1 or 3 regulates expression and tyrosine phosphorylation of FAK, while also enhancing activation of RhoA. Our novel findings suggest that SOCS1 and 3 may control chemotaxis and adhesion by significantly enhancing both FAK and RhoA activity, thus localizing immune cells to the site of allergic inflammation.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934424     DOI: 10.1016/j.febslet.2010.10.007

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Slit2 regulates the dispersal of oligodendrocyte precursor cells via Fyn/RhoA signaling.

Authors:  Xiujie Liu; Yan Lu; Yong Zhang; Yuanyuan Li; Jiazhen Zhou; Yimin Yuan; Xiaofei Gao; Zhida Su; Cheng He
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

3.  C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

Authors:  Hang Li; Bo Zhang; Meng Ding; Shang Lu; Hui Zhou; Dajun Sun; Gang Wu; Xianfeng Gan
Journal:  Hepatol Int       Date:  2019-05-08       Impact factor: 6.047

Review 4.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

Review 5.  Complexity of Interferon-γ Interactions with HSV-1.

Authors:  Nancy J Bigley
Journal:  Front Immunol       Date:  2014-02-06       Impact factor: 7.561

6.  Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.

Authors:  Weijie Han; Guofeng Yu; Xianmei Meng; Hong Hong; Liansheng Zheng; Xiaobo Wu; Dongsheng Zhang; Boshi Yan; Yongqiang Ma; Xiaolong Li; Qiuhong Wang
Journal:  Mol Cell Biochem       Date:  2019-06-06       Impact factor: 3.396

7.  Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses.

Authors:  Ji Young Hwang; John E Holland; Kristine B Valenteros; Yanbo Sun; Young-Kwang Usherwood; Andreia F Verissimo; Jason S McLellan; Gevorg Grigoryan; Edward J Usherwood
Journal:  Immunohorizons       Date:  2019-11-20

8.  miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.

Authors:  Aideen S Collins; Claire E McCoy; Andrew T Lloyd; Cliona O'Farrelly; Nigel J Stevenson
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.